In addition, targeting MLN4924 in uveal melanoma cells (UMs) can reduce the paracrine secretion of vascular endothelial growth factor-C (VEGF-C) in an NF-κB-dependent manner [62]. The gene discussed is VEGFC; the disease is uveal melanoma.